These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 4039189)

  • 1. Pharmacokinetics of aztreonam in elderly male volunteers.
    Creasey WA; Platt TB; Frantz M; Sugerman AA
    Br J Clin Pharmacol; 1985 Feb; 19(2):233-7. PubMed ID: 4039189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of aztreonam in patients with chronic renal failure.
    Fillastre JP; Leroy A; Baudoin C; Humbert G; Swabb EA; Vertucci C; Godin M
    Clin Pharmacokinet; 1985; 10(1):91-100. PubMed ID: 4038635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolism and pharmacokinetics of aztreonam in healthy subjects.
    Swabb EA; Singhvi SM; Leitz MA; Frantz M; Sugerman A
    Antimicrob Agents Chemother; 1983 Sep; 24(3):394-400. PubMed ID: 6685455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of aztreonam in healthy elderly and young adult volunteers.
    Meyers BR; Wilkinson P; Mendelson MH; Bournazos C; Tejero C; Hirschman SZ
    J Clin Pharmacol; 1993 May; 33(5):470-4. PubMed ID: 8331206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical pharmacokinetics of aztreonam in cancer patients.
    Jones PG; Bodey GP; Swabb EA; Ho DH; Fainstein V; Pasternak J
    Antimicrob Agents Chemother; 1984 Oct; 26(4):455-61. PubMed ID: 6542763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Review of single- and multiple-dose pharmacokinetics of the monobactam, aztreonam (SQ 26,776) in healthy subjects.
    Swabb EA; Sugerman AA
    Chemotherapy; 1983; 29(5):313-21. PubMed ID: 6684541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single-dose pharmacokinetics of aztreonam in healthy volunteers and renal failure patients.
    el Guinaidy MA; Nawishy S; Abd el Bary M; Sabbour MS
    J Chemother; 1989 Jun; 1(3):164-9. PubMed ID: 2795125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of aztreonam in patients with various degrees of renal dysfunction.
    Mihindu JC; Scheld WM; Bolton ND; Spyker DA; Swabb EA; Bolton WK
    Antimicrob Agents Chemother; 1983 Aug; 24(2):252-61. PubMed ID: 6685452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single-dose pharmacokinetics of aztreonam in pediatric patients.
    Stutman HR; Marks MI; Swabb EA
    Antimicrob Agents Chemother; 1984 Aug; 26(2):196-9. PubMed ID: 6541452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and tissue penetration of carumonam, a new synthetic monobactam.
    McNulty CA; Garden GM; Ashby J; Wise R
    Antimicrob Agents Chemother; 1985 Sep; 28(3):425-7. PubMed ID: 4073864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety of aztreonam and SQ 26,992 in elderly patients with renal insufficiency.
    Sattler FR; Schramm M; Swabb EA
    Rev Infect Dis; 1985; 7 Suppl 4():S622-7. PubMed ID: 4081474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple-dose pharmacokinetics of the monobactam azthreonam (SQ 26,776) in healthy subjects.
    Swabb EA; Sugerman AA; McKinstry DN
    Antimicrob Agents Chemother; 1983 Jan; 23(1):125-32. PubMed ID: 6681947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of Aztreonam Dosing Regimens in Patients With Normal and Impaired Renal Function: A Population Pharmacokinetic Modeling and Monte Carlo Simulation Analysis.
    Xu H; Zhou W; Zhou D; Li J; Al-Huniti N
    J Clin Pharmacol; 2017 Mar; 57(3):336-344. PubMed ID: 27530649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single-dose pharmacokinetics of aztreonam in children with cystic fibrosis.
    Reed MD; Aronoff SC; Stern RC; Yamashita TS; Myers CM; Friedhoff LT; Blumer JL
    Pediatr Pulmonol; 1986; 2(5):282-6. PubMed ID: 3774385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-dose pharmacokinetics of Ro 17-2301 (AMA-1080), a monocyclic beta-lactam, in humans.
    Weidekamm E; Stoeckel K; Egger HJ; Ziegler WH
    Antimicrob Agents Chemother; 1984 Dec; 26(6):898-902. PubMed ID: 6395801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single-dose pharmacokinetics of the monobactam azthreonam (SQ 26,776) in healthy subjects.
    Swabb EA; Sugerman AA; Platt TB; Pilkiewicz FG; Frantz M
    Antimicrob Agents Chemother; 1982 Jun; 21(6):944-9. PubMed ID: 7202343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics and tissue penetration of azthreonam.
    Wise R; Dyas A; Hegarty A; Andrews JM
    Antimicrob Agents Chemother; 1982 Dec; 22(6):969-71. PubMed ID: 6891575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of aztreonam pharmacokinetics in humans based on data from animals.
    Swabb EA; Bonner DP
    J Pharmacokinet Biopharm; 1983 Jun; 11(3):215-23. PubMed ID: 6685766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacology of aztreonam after intravenous infusion.
    Scully BE; Swabb EA; Neu HC
    Antimicrob Agents Chemother; 1983 Jul; 24(1):18-22. PubMed ID: 6684898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics and dose recommendations of carumonam in renal failure.
    Koeppe P; Höffler D; Strobel K
    Arzneimittelforschung; 1987 Jan; 37(1):65-9. PubMed ID: 3566860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.